Table 3.
Antimicrobial resistance monitoring and vigilance in Egypt and the UK
| Country | One health programs | Significance |
|---|---|---|
| Egypt |
National Action Plan on Antibiotic Resistance https://www.who.int/publications/m/item/egypt-national-action-plan-for-antimicrobial-resistance Accessed 28 January 2022 |
Control AMR by raising public health awareness, strengthen infection control measures, containment of the emergence and spread of AMR organisms, activate Lab-based surveillance system, rational use of antimicrobials and finding novel therapies |
|
Global Action Plan (GAP) |
Infection prevention and control, AMR surveillance and management supported by the antimicrobial stewardship program, raising public awareness, investing in new medicines, and a variety of other interventions | |
|
Global Antimicrobial Resistance and Use Surveillance System (GLASS) https://www.paho.org/en/documents/global-antimicrobial-resistance-and-use-surveillance-system-glass-report-2022 |
It promotes nations to adopt surveillance methods based on systems that include epidemiological, clinical, and population-level data rather than only laboratory data and fosters the development of the AMR evidence | |
| UK |
UK’s National Action Plan |
It sets out commitments in line with the Open Government Partnership values of access to information, civic involvement, public accountability, and technology and innovation |
|
WHO’s Global Antimicrobial Resistance Surveillance System (GLASS) |
Provides a standardized approach for countries to collect, analyses, and share AMR data, with the goal of supporting capacity development and monitoring the status of existing or newly formed national AMR surveillance systems | |
|
European Antimicrobial Resistance Surveillance Network (EARS-Net) |
Evaluate the overall comparability of routinely collected test results and assess the accuracy of quantitative antimicrobial susceptibility test results |